The 2018 Nobel Prize in Chemistry has been awarded to three scientists who tapped into evolution to produce vital chemicals. It was awarded to Frances H. Arnold for directing the evolution of enzymes, and to George P. Smith and Sir Gregory P. Winter, who manipulated phages to create new antibodies.
Continue Reading
Mostly known for its lustrous fleece and predilection for vigorous spitting, the humble alpaca may soon be more famous for its novel immune system. A study has discovered that the animals produce a unique nanobody that could be recruited into a new treatment for cancer.
Continue Reading
HIV is a life sentence, but it can be managed through antiretroviral therapy. New clinical trials in humans have shown that drugs based on two antibodies naturally found in some people can put HIV into hiding for months at a time.
Continue Reading
Melanoma, a common type of skin cancer, is traditionally detected via observing changes in irregular moles, and then conducting a skin biopsy. A team has now developed a blood test that can detect melanoma in its early stages, reducing the need for expensive, and frequently unnecessary biopsies.
Continue Reading
After successful and safe clinical trials, the FDA has approved a first-of-its-kind migraine preventative medicine. It's the first in an entirely new class of drugs designed to block the activity of a specific peptide known to activate migraines that has been cleared for public use by the agency.
Continue Reading
Researchers from Washington University have tested a new weapon in the fight against Alzheimer’s. In mice, the team has demonstrated an antibody that can clear away the disease’s build-up of proteins in the brain, which may lead to an early-stage treatment to prevent symptoms from occurring.
Continue Reading
Researchers have revealed the mechanism behind an antibody that can potentially inactivate the body's allergic processes. The breakthrough brings researchers one step closer to developing a universal treatment that can prevent the fundamental immune response at the heart of all allergic reactions.
Continue Reading
A new antibody treatment developed specifically for migraine prevention has just completed Phase III human clinical trials with remarkably positive results, raising hopes of a possible revolution on the horizon for sufferers of this debilitating condition.
Continue Reading
Stem cells are the blank slate on which all the specialized cells in our bodies are built, and finding ways to revert adult cells back to that stage can help fight a whole range of illnesses. Now scientists at the Scripps Research Institute have found human antibodies that can perform the function.
Continue Reading
The fight against Ebola continues with news of a new outbreak in the Republic of Congo. That said, a discovery by scientists at the Albert Einstein College of Medicine offers reason to be optimistic: they have found the first human antibodies that can neutralize all strains of ebolavirus.
Continue Reading
See the stories that matter in your inbox every morning